Danaher’s $9.9B Masimo Deal Marks One of 2026’s Largest Medtech Buyouts
Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped 30.27% ...
Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped 30.27% ...
|November 17, 2025|Last update:November 17, 2025Image credits: Sofinnova Partners Sofinnova Partners closes its €650M flagship fund to back early-stage biotech ...
Dutch AI company Guideways, helping medtech businesses navigate regulatory and compliance, has raised pre-seed financing. Get access to the full ...
Copyright © 2022-2024
All Rights Reserved
See articles for original source and related links to external sites.
Copyright © 2022-2024
All Rights Reserved
See articles for original source and related links to external sites.